Skip to main content

Iquix FDA Approval History

FDA Approved: Yes (Discontinued) (First approved March 1, 2004)
Brand name: Iquix
Generic name: levofloxacin ophthalmic
Dosage form: Ophthalmic Solution
Company: Santen
Treatment for: Corneal Ulcer

Marketing Status: Discontinued

Iquix (levofloxacin) is a topical fluoroquinolone indicated for the treatment of bacterial corneal ulcers.

Development timeline for Iquix

Mar  1, 2004Approval Iquix Santen - Treatment for Bacterial Corneal Ulcers

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.